
CERo Therapeutics Holdings, Inc. Common Stock
CERO Real Time Price USDRecent trades of CERO by members of U.S. Congress
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by CERO's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
CERO Revenue by Segment or Geography

No Revenue by Segment data for this ticker

No Revenue by Geography data for this ticker
New patents grants
-
Patent Title: Chimeric engulfment receptor molecules and methods of use Jul. 25, 2023
-
Patent Title: Chimeric engulfment receptor molecules May. 23, 2023
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to CERO
Number of mentions of CERO in WallStreetBets Daily Discussion
Recent picks made for CERO stock on CNBC
ETFs with the largest estimated holdings in CERO
Shareholder
|
Shares Held
|
---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CERO Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.